241 related articles for article (PubMed ID: 32058943)
1. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.
Meroni M; Dongiovanni P; Longo M; Carli F; Baselli G; Rametta R; Pelusi S; Badiali S; Maggioni M; Gaggini M; Fracanzani AL; Romeo S; Gatti S; Davidson NO; Gastaldelli A; Valenti L
EBioMedicine; 2020 Feb; 52():102658. PubMed ID: 32058943
[TBL] [Abstract][Full Text] [Related]
2. LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.
Tanaka Y; Shimanaka Y; Caddeo A; Kubo T; Mao Y; Kubota T; Kubota N; Yamauchi T; Mancina RM; Baselli G; Luukkonen P; Pihlajamäki J; Yki-Järvinen H; Valenti L; Arai H; Romeo S; Kono N
Gut; 2021 Jan; 70(1):180-193. PubMed ID: 32253259
[TBL] [Abstract][Full Text] [Related]
3. MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.
Massey WJ; Varadharajan V; Banerjee R; Brown AL; Horak AJ; Hohe RC; Jung BM; Qiu Y; Chan ER; Pan C; Zhang R; Allende DS; Willard B; Cheng F; Lusis AJ; Brown JM
J Lipid Res; 2023 Apr; 64(4):100349. PubMed ID: 36806709
[TBL] [Abstract][Full Text] [Related]
4. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
[TBL] [Abstract][Full Text] [Related]
5. Loss of hepatic Mboat7 leads to liver fibrosis.
Thangapandi VR; Knittelfelder O; Brosch M; Patsenker E; Vvedenskaya O; Buch S; Hinz S; Hendricks A; Nati M; Herrmann A; Rekhade DR; Berg T; Matz-Soja M; Huse K; Klipp E; Pauling JK; Wodke JA; Miranda Ackerman J; Bonin MV; Aigner E; Datz C; von Schönfels W; Nehring S; Zeissig S; Röcken C; Dahl A; Chavakis T; Stickel F; Shevchenko A; Schafmayer C; Hampe J; Subramanian P
Gut; 2021 May; 70(5):940-950. PubMed ID: 32591434
[TBL] [Abstract][Full Text] [Related]
6. The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation.
Panera N; Meroni M; Longo M; Crudele A; Valenti L; Bellacchio E; Miele L; D'Oria V; Paolini E; Maggioni M; Fracanzani AL; Alisi A; Dongiovanni P
EBioMedicine; 2021 Mar; 65():103249. PubMed ID: 33640795
[TBL] [Abstract][Full Text] [Related]
7. LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol.
Caddeo A; Hedfalk K; Romeo S; Pingitore P
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158891. PubMed ID: 33513444
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
9. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
[TBL] [Abstract][Full Text] [Related]
10. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
11. Obesity-linked suppression of membrane-bound
Helsley RN; Varadharajan V; Brown AL; Gromovsky AD; Schugar RC; Ramachandiran I; Fung K; Kabbany MN; Banerjee R; Neumann CK; Finney C; Pathak P; Orabi D; Osborn LJ; Massey W; Zhang R; Kadam A; Sansbury BE; Pan C; Sacks J; Lee RG; Crooke RM; Graham MJ; Lemieux ME; Gogonea V; Kirwan JP; Allende DS; Civelek M; Fox PL; Rudel LL; Lusis AJ; Spite M; Brown JM
Elife; 2019 Oct; 8():. PubMed ID: 31621579
[TBL] [Abstract][Full Text] [Related]
12. Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
Zusi C; Morandi A; Maguolo A; Corradi M; Costantini S; Mosca A; Crudele A; Mantovani A; Alisi A; Miraglia Del Giudice E; Targher G; Maffeis C
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1548-1555. PubMed ID: 33810963
[TBL] [Abstract][Full Text] [Related]
13. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
16. MBOAT7 in liver and extrahepatic diseases.
Caddeo A; Spagnuolo R; Maurotti S
Liver Int; 2023 Nov; 43(11):2351-2364. PubMed ID: 37605540
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis.
Sharpe MC; Pyles KD; Hallcox T; Kamm DR; Piechowski M; Fisk B; Albert CJ; Carpenter DH; Ulmasov B; Ford DA; Neuschwander-Tetri BA; McCommis KS
Gastro Hep Adv; 2023; 2(4):558-572. PubMed ID: 37293574
[TBL] [Abstract][Full Text] [Related]
18. Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease.
Varadharajan V; Massey WJ; Brown JM
J Lipid Res; 2022 Jul; 63(7):100234. PubMed ID: 35636492
[TBL] [Abstract][Full Text] [Related]
19. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver.
Xia M; Chandrasekaran P; Rong S; Fu X; Mitsche MA
J Lipid Res; 2021; 62():100031. PubMed ID: 32859645
[TBL] [Abstract][Full Text] [Related]
20. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis.
Teo K; Abeysekera KWM; Adams L; Aigner E; Anstee QM; Banales JM; Banerjee R; Basu P; Berg T; Bhatnagar P; Buch S; Canbay A; Caprio S; Chatterjee A; Ida Chen YD; Chowdhury A; Daly AK; Datz C; de Gracia Hahn D; DiStefano JK; Dong J; Duret A; ; Emdin C; Fairey M; Gerhard GS; ; Guo X; Hampe J; Hickman M; Heintz L; Hudert C; Hunter H; Kelly M; Kozlitina J; Krawczyk M; Lammert F; Langenberg C; Lavine J; Li L; Lim HK; Loomba R; Luukkonen PK; Melton PE; Mori TA; Palmer ND; Parisinos CA; Pillai SG; Qayyum F; Reichert MC; Romeo S; Rotter JI; Im YR; Santoro N; Schafmayer C; Speliotes EK; Stender S; Stickel F; Still CD; Strnad P; Taylor KD; Tybjærg-Hansen A; Umano GR; Utukuri M; Valenti L; Wagenknecht LE; Wareham NJ; Watanabe RM; Wattacheril J; Yaghootkar H; Yki-Järvinen H; Young KA; Mann JP
J Hepatol; 2021 Jan; 74(1):20-30. PubMed ID: 32882372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
